A Vancouver-based biotech company brought its genetic know-how to Pfizer’s COVID-19 vaccine development. Thomas Madden, president and CEO of Acuitas Therapeutics, explains his company’s contribution to the vaccine effort.
Posted in
#canadatech #canadatechnology #canadian #canadiannews #canadianreports #canadiantech Search Canada Online Listing Technology

